These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 24563276)
1. Multichannel intraluminal impedance-pH testing is clinically useful in the management of patients with gastroesophageal reflux symptoms. Jodorkovsky D; Price JC; Kim B; Dhalla S; Stein EM; Clarke JO Dig Dis Sci; 2014 Aug; 59(8):1817-22. PubMed ID: 24563276 [TBL] [Abstract][Full Text] [Related]
2. Can Impedance-pH Testing on Medications Reliably Identify Patients with GERD as Defined by Pathologic Esophageal Acid Exposure off Medications? Ward MA; Dunst CM; Glasgow ME; Teitelbaum EN; Abdelmoaty WF; Reavis KM; Swanstrӧm LL; DeMeester SR J Gastrointest Surg; 2019 Jul; 23(7):1301-1308. PubMed ID: 30859425 [TBL] [Abstract][Full Text] [Related]
3. Impedance-pH monitoring on medications does not reliably confirm the presence of gastroesophageal reflux disease in patients referred for antireflux surgery. Ward MA; Dunst CM; Teitelbaum EN; Halpin VJ; Reavis KM; Swanström LL; DeMeester SR Surg Endosc; 2018 Feb; 32(2):889-894. PubMed ID: 28779252 [TBL] [Abstract][Full Text] [Related]
4. Multichannel intraluminal impedance in the evaluation of patients with persistent globus on proton pump inhibitor therapy. Anandasabapathy S; Jaffin BW Ann Otol Rhinol Laryngol; 2006 Aug; 115(8):563-70. PubMed ID: 16944654 [TBL] [Abstract][Full Text] [Related]
5. Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they? de Bortoli N; Martinucci I; Savarino E; Bellini M; Bredenoord AJ; Franchi R; Bertani L; Furnari M; Savarino V; Blandizzi C; Marchi S Neurogastroenterol Motil; 2014 Jan; 26(1):28-35. PubMed ID: 23992024 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of Gastroesophageal Reflux by Combined Multichannel Intraluminal Impedance and pH Monitoring and Esophageal Motility Patterns in Children with Esophageal Atresia. Tong S; Mallitt KA; Krishnan U Eur J Pediatr Surg; 2016 Aug; 26(4):322-31. PubMed ID: 26445355 [TBL] [Abstract][Full Text] [Related]
7. Combined esophageal multichannel intraluminal impedance and pH monitoring (MII -pH) in the diagnostics and treatment of gastroesophageal reflux disease and its complications. Masiak W; Wallner G; Wallner J; Pedowski T; Solecki M Pol Przegl Chir; 2011 Sep; 83(9):488-96. PubMed ID: 22166737 [TBL] [Abstract][Full Text] [Related]
8. The utility of multichannel intraluminal impedance-pH testing in tailoring the management of paediatric gastro-oesophageal reflux disease. Gunasagaran HL; Varjavandi V; Lemberg DA; Ooi CY; Gupta N; Krishnan U Acta Paediatr; 2020 Dec; 109(12):2799-2807. PubMed ID: 32304594 [TBL] [Abstract][Full Text] [Related]
9. Tailored therapy for the refractory GERD patients by combined multichannel intraluminal impedance-pH monitoring. Xiao Y; Liang M; Peng S; Zhang N; Chen M J Gastroenterol Hepatol; 2016 Feb; 31(2):350-4. PubMed ID: 26202002 [TBL] [Abstract][Full Text] [Related]
10. Twice-daily proton pump inhibitor therapy does not decrease the frequency of reflux episodes during nocturnal recumbency in patients with refractory GERD: analysis of 200 patients using multichannel intraluminal impedance-pH testing. Clayton SB; Rife CC; Singh ER; Kalbfleisch JH; Castell DO Dis Esophagus; 2012; 25(8):682-6. PubMed ID: 22292567 [TBL] [Abstract][Full Text] [Related]
11. Pre-lung transplant measures of reflux on impedance are superior to pH testing alone in predicting early allograft injury. Lo WK; Burakoff R; Goldberg HJ; Feldman N; Chan WW World J Gastroenterol; 2015 Aug; 21(30):9111-7. PubMed ID: 26290637 [TBL] [Abstract][Full Text] [Related]
12. High-dose esomeprazole for treatment of symptomatic refractory gastroesophageal reflux disease--a prospective pH-metry/impedance-controlled study. Bajbouj M; Becker V; Phillip V; Wilhelm D; Schmid RM; Meining A Digestion; 2009; 80(2):112-8. PubMed ID: 19641320 [TBL] [Abstract][Full Text] [Related]
13. Reflux pattern and role of impedance-pH variables in predicting PPI response in patients with suspected GERD-related chronic cough. Ribolsi M; Savarino E; De Bortoli N; Balestrieri P; Furnari M; Martinucci I; Casale M; Greco F; Salvinelli F; Savarino V; Marchi S; Cicala M Aliment Pharmacol Ther; 2014 Oct; 40(8):966-73. PubMed ID: 25109844 [TBL] [Abstract][Full Text] [Related]
14. Prospective study examining the impact of multichannel intraluminal impedance on antireflux surgery. Gruebel C; Linke G; Tutuian R; Hebbard G; Zerz A; Meyenberger C; Borovicka J Surg Endosc; 2008 May; 22(5):1241-7. PubMed ID: 17943361 [TBL] [Abstract][Full Text] [Related]
15. Usefulness of baseline impedance in patients with proton pump inhibitor-refractory nonerosive reflux disease. Kohata Y; Fujiwara Y; Yamagami H; Tanigawa T; Shiba M; Watanabe K; Watanabe T; Tominaga K; Arakawa T J Gastroenterol Hepatol; 2015 Mar; 30 Suppl 1():36-40. PubMed ID: 25827802 [TBL] [Abstract][Full Text] [Related]
16. Positive predictors for gastroesophageal reflux disease and the therapeutic response to proton-pump inhibitors. Becker V; Grotz S; Schlag C; Nennstiel S; Beitz A; Haller B; Schmid RM; Meining A; Bajbouj M World J Gastroenterol; 2014 Apr; 20(14):4017-24. PubMed ID: 24744591 [TBL] [Abstract][Full Text] [Related]
17. How many cases of laryngopharyngeal reflux suspected by laryngoscopy are gastroesophageal reflux disease-related? de Bortoli N; Nacci A; Savarino E; Martinucci I; Bellini M; Fattori B; Ceccarelli L; Costa F; Mumolo MG; Ricchiuti A; Savarino V; Berrettini S; Marchi S World J Gastroenterol; 2012 Aug; 18(32):4363-70. PubMed ID: 22969200 [TBL] [Abstract][Full Text] [Related]
18. Predictors of proton pump inhibitor failure in non-erosive reflux disease: A study with impedance-pH monitoring and high-resolution manometry. Shi Y; Tan N; Zhang N; Xiong L; Peng S; Lin J; Chen M; Xiao Y Neurogastroenterol Motil; 2016 May; 28(5):674-9. PubMed ID: 26768192 [TBL] [Abstract][Full Text] [Related]
19. Tailored therapy guided by multichannel intraluminal impedance pH monitoring for refractory non-erosive reflux disease. Ranaldo N; Losurdo G; Iannone A; Principi M; Barone M; De Carne M; Ierardi E; Di Leo A Cell Death Dis; 2017 Sep; 8(9):e3040. PubMed ID: 28880273 [TBL] [Abstract][Full Text] [Related]